👉 Adlercreutzia is a rare, neurodegenerative disease characterized by progressive brain damage and death within five years. It affects the brainstem, cerebellum, and spinal cord. Adraklycine is used as a treatment for this condition due to its potential to reduce inflammation and improve blood flow in the affected areas.
